Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | TACR2 | P21452 | 3/20 | 0.48 |
| ▸ | TACR3 | P29371 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7287023 | 0.84 | MEN1 (0.60) | MEN1KMT2AHPGDCD274POLB | |
| SCHEMBL12310426 | 0.84 | MEN1 (0.60) | MEN1KMT2AHPGDCD274POLB | |
| SCHEMBL7405696 | 0.82 | TACR2 (0.62) | KMT2ATACR2LMNAALDH1A1 | |
| SCHEMBL3586021 | 0.81 | KMT2A (0.46) | MEN1KMT2APOLBLMNAALDH1A1 | |
| SCHEMBL3586820 | 0.79 | SLC1A1 (0.52) | LMNA | |
| SCHEMBL7653278 | 0.79 | HSD17B10 (0.67) | MEN1KMT2AHPGDCD274TACR3 | |
| SCHEMBL12310313 | 0.78 | TACR3 (0.59) | HPGDCD274TACR2TACR3LMNA | |
| SCHEMBL6044214 | 0.78 | MEN1 (0.57) | MEN1KMT2AHPGDCD274POLB | |
| SCHEMBL12260483 | 0.78 | TACR3 (0.59) | HPGDCD274TACR2TACR3LMNA | |
| SCHEMBL30899745 | 0.77 | MEN1 (0.58) | MEN1KMT2AHPGDCD274POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | MEN1 488/4885KMT2A 2996/4885HPGD 4277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.